These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 5974487)
1. [Determination of the effective dose for the in-vitro destruction of Ehrlich mice ascites carcinoma cells by nitrogen mustard oxide]. von Ardenne M; Reitnauer PG Acta Biol Med Ger; 1966; 16(1):43-53. PubMed ID: 5974487 [No Abstract] [Full Text] [Related]
2. [Correlations between chemical structure and biological activity of azomethines with nitrogen-mustard-groups on Ehrlich ascites tumor in albino mice. 3. Activation of N-mustard-azomethines by cells of Ehrlich ascites carcinoma]. Schulze W; Horn G Arzneimittelforschung; 1970 Mar; 20(3):329-35. PubMed ID: 5467506 [No Abstract] [Full Text] [Related]
3. A study on the mechanism of resistance to nitrogen mustard (HN2) in Ehrlich ascites tumor cells: comparison of uptake of HN2-14-C into sensitive and resistant cells. Wolpert MK; Ruddon RW Cancer Res; 1969 Apr; 29(4):873-9. PubMed ID: 5775714 [No Abstract] [Full Text] [Related]
4. Studies on the effect of homo-aza-steroidal ester of p-bis (2-chloroethyl) amino phenyl acetic acid in Ehrlich ascites tumor cells. Papageorgiou A; Koliais SI; Antonoglou O; Catsoulacos P; Boutis L Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):5-9. PubMed ID: 6717170 [TBL] [Abstract][Full Text] [Related]
5. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)]. Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676 [No Abstract] [Full Text] [Related]
6. [Relationships between chemical structure and biological activity in azomethines with nitrogen mustard groups on Ehrlich ascites tumor of the white mouse. 2. Azomethine without N-mustard groups as comparative substances and N-mustard azomethine with additional substitutions in the phenyl group]. Schulze W; Gutsche W; Jungstand W Arzneimittelforschung; 1967 May; 17(5):605-7. PubMed ID: 5631589 [No Abstract] [Full Text] [Related]
7. Differences in the in vivo alkylation and cross-linking of nitrogen mustard-sensitive and -resistant lines of Lettré-Ehrlich asites tumors. Chun EH; Gonzales L; Lewis FS; Jones J; Rutman RJ Cancer Res; 1969 Jun; 29(6):1184-94. PubMed ID: 5797106 [No Abstract] [Full Text] [Related]
8. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180. Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510 [TBL] [Abstract][Full Text] [Related]
9. The effect of nitrogen mustards on glutamate metabolism in rat liver mitochondria and Ehrlich ascites cells. Raczyńska-Bojanowska K; Gasiorowska I Acta Biochim Pol; 1966; 13(2):113-20. PubMed ID: 5914476 [No Abstract] [Full Text] [Related]
10. The synergic action of the bovine growth hormone with some cytostatic drugs in the experimental therapy of Ehrlich and NK-Ly ascites tumors in mice. Baranowicz JW Neoplasma; 1973; 20(1):47-50. PubMed ID: 4121992 [No Abstract] [Full Text] [Related]
11. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180]. Jugstand W; Gutsche W; Wiangke H Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431 [No Abstract] [Full Text] [Related]
12. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice]. Werner W; Jungstand W; Gutsche W Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470 [No Abstract] [Full Text] [Related]
13. Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells. Draeger U; Hohorst HJ Cancer Treat Rep; 1976 Apr; 60(4):423-7. PubMed ID: 1277217 [TBL] [Abstract][Full Text] [Related]
14. The effect of high pressure oxygen and nitrogen mustard on the Ehrlich ascites tumor. Cohen A; Weg N; Fanning GL; Collea JV; Russo MA; Rogers LS; DeCosse JJ Arch Surg; 1966 Oct; 93(4):638-42. PubMed ID: 5922037 [No Abstract] [Full Text] [Related]
15. [Metabolism of nitrogen in Ehrlich ascites tumor cells: role of glutamine and ammonium]. Carrascosa JM; Martínez P; Núñez de Castro I Rev Esp Oncol; 1983; 30(4):533-7. PubMed ID: 6599917 [TBL] [Abstract][Full Text] [Related]
16. [Daily periodic variations in the potency of the cancerostatic effect of nitrogen mustard oxide in Ehrlich ascites carcinoma in mice]. POHLE K; MATTHIES E; MENG K Z Krebsforsch; 1961; 64():215-18. PubMed ID: 13736566 [No Abstract] [Full Text] [Related]
17. Nitrogen mustard interference with potassium transport systems in Ehrlich ascites tumor cells. Doppler W; Hofmann J; Oberhuber H; Maly K; Grunicke H J Cancer Res Clin Oncol; 1985; 110(1):35-41. PubMed ID: 4019567 [TBL] [Abstract][Full Text] [Related]
18. [The time dependent, electronically measured change in volume frequency distribution of Ehrlich ascites tumor cells after treatment with alkylating cytostatics in vivo]. Gutsche W Arzneimittelforschung; 1971 Apr; 21(4):444-6. PubMed ID: 5108137 [No Abstract] [Full Text] [Related]
19. Increase in dry mass of Ehrlich ascites tumor cells after treatment with nitrogen mustard. LEE H; RICHARDS V; FURST A Cancer Res; 1961 Oct; 21():1108-12. PubMed ID: 14463490 [No Abstract] [Full Text] [Related]
20. [Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor]. Papoian SA; Kumkumadzhian VA Vopr Onkol; 1966 Apr; 12(4):56-61. PubMed ID: 6001002 [No Abstract] [Full Text] [Related] [Next] [New Search]